Real-time enrollment status for this single ventricle heart disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:35 AM UTC
| NCT Number | NCT05918211 |
| Recruiting Status | Recruiting |
| Condition | Single Ventricle Heart Disease |
| Phase | PHASE3 |
| Target Enrollment | 436 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Mezzion Pharma Co. Ltd |
| Last Updated on CT.gov | October 28, 2025 (Oct 28, 2025) |
As of July 17, 2026: Clinical trial NCT05918211 is currently recruiting participants. This phase3 study for single ventricle heart disease is actively seeking new participants at 37 locations across the United States. The study is sponsored by Mezzion Pharma Co. Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05918211 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05918211 was last updated Oct 28, 2025 (October 28, 2025). HelloStudys verifies this status automatically.